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Background: A minor but significant fraction of samples subjected to next-generation sequencing methods are
either mixed-up or cross-contaminated. These events can lead to false or inconclusive results. We have therefore
developed SASI-Seq; a process whereby a set of uniquely barcoded DNA fragments are added to samples destined
for sequencing. From the final sequencing data, one can verify that all the reads derive from the original sample(s)
and not from contaminants or other samples.
Results: By adding a mixture of three uniquely barcoded amplicons, of different sizes spanning the range of insert
sizes one would normally use for Illumina sequencing, at a spike-in level of approximately 0.1%, we demonstrate
that these fragments remain intimately associated with the sample. They can be detected following even the
tightest size selection regimes or exome enrichment and can report the occurrence of sample mix-ups and
cross-contamination.
As a consequence of this work, we have designed a set of 384 eleven-base Illumina barcode sequences that are at
least 5 changes apart from each other, allowing for single-error correction and very low levels of barcode
misallocation due to sequencing error.
Conclusion: SASI-Seq is a simple, inexpensive and flexible tool that enables sample assurance, allows deconvolution of
sample mix-ups and reports levels of cross-contamination between samples throughout NGS workflows.
Keywords: Next-generation sequencing, Indexing, Barcode, Illumina, Sample assurance, Spike-in, Contamination,
Sample identityBackground
As NGS matures and sequence yields increase, the scale
of sequencing projects being undertaken is ever increasing.
There are now many sequencing projects tackling thou-
sands, or tens of thousands of samples; e.g., the UK10K
project (www.uk10k.org) and the malaria genome consor-
tium [1]. Large sample numbers from both case and
control sets are commonly being sequenced in order to
detect rare alleles that are associated with disease.
Sample contamination and mix-ups are a serious problem,
and can interfere with the sensitive statistical methods
being used to determine such causal variants [2-7]. Whilst* Correspondence: mq1@sanger.ac.uk
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stated.laboratories can implement elaborate tracking procedures
involving barcoding and automated handling, sample
swaps, plate swaps, and cross-contamination can still
occur [8,9]. Recent analyses using coxI phylogenetic
relationships suggest that up to 5% error may exist in
sequence database entries [10], but do not have the
power to determine the cause of that error. In the human
genome project, clone identity could be verified by cross-
matching in-silico digestion patterns of the final sequence
against DNA fingerprinting information generated during
physical map construction [11]. In the 1000 genome
project [12] sample identity was verified by comparison
of sequence variation to the Hap Map database infor-
mation for the corresponding sample and bioinformatics
tools were written to assess levels of cross-contaminationtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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These approaches however are expensive, requiring sig-
nificant work that may preclude their use for larger
sequencing projects and fast turn-around clinical sequen-
cing projects. Furthermore, they are sometimes not sensi-
tive enough to unambiguously identify a sample and they
report only the bulk properties of a sample and would
therefore not be able to report minor cross-contamination
events.
Thus, we have conceived SASI-Seq (Sample Assurance
Spike-In sequencing) whereby uniquely barcoded DNA
fragments are spiked into samples at the onset. A given
SASI tag will stay intimately associated with a sample as it
is processed through library preparation and sequencing
set-up (Figure 1). The sequence of that tag will be read at
the same time that a sample is sequenced, thus allowing
unambiguous identification of a sample by virtue of its
reported SASI tag sequence. The spike-in can be done at
low levels that would nonetheless generate a large enough
number of reads to enable identification of minor contam-
inants. The idea of spiked-in fragments is not new; ERCC
RNA spike-ins [14] are routinely used to normalise RNA
expression levels between different experiments, combina-
tions of primer pairs specifying control fragments of
defined length have been advocated for genotyping studies
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Figure 1 Diagrammatic representation of the SASI-Seq process. Ampl
with unique barcodes at their 5’ end. Sets of amplicons with different barc
SASI fragments stay with the sample through library prep and can be detecte
data originated from. FA, FB and FC represent the forward primers for the 214
5’ end shown here in red. R is the reverse SASI fragment primer also having a
detailed in Methods.diagnose the efficiency of library preparation steps, within
their TruSeq kits.
The present method, however, has much wider utility,
providing assurance that a sequence has come from the
correct sample. Without such assurance, sample swaps
and cross-contamination often go unnoticed, resulting in
erroneous or confusing results, both of which could be
disastrous for clinical sequencing applications.
With the introduction of massively parallel next-
generation sequencing technologies came the realisation
that a single sequencing run often yielded too many reads,
particularly for smaller genomes and amplicons. Methods
were developed to multiplex samples, involving the
addition of a different unique short barcode sequence to
each sample during library preparation. Subsequently, they
could be mixed, sequenced together and the reads correctly
attributed to the appropriate sample by binning reads
containing the same barcode sequence. This practice was
first reported for Roche 454 sequencing [16,17], and soon
after for the Illumina platform [18]. As sequencing yields
have risen higher, the degree of multiplexing has also
risen, with Kozarewa and Turner (2011) reporting a set of
96 barcodes [19], Caporaso et al., (2012) describing a set
of 2167 barcodes [20] and Costea et al., (2013) developing
the software tool TagGD that can design up to 20,000-plex




Seed incoming samples with unique combinations of spike-in fragments. 
icons of a reference sequence (here we use PhiX174) are generated
odes are added to each sample that is destined for sequencing. The
d after sequencing. SASI-Seq thus verifies which sample the sequence
, 397 and 568 bp SASI fragments respectively, with SASI barcodes at the
SASI barcode at the 5’ end, here coloured in red. Primer sequences are
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[22,23] with an edit distance of 4 (i.e. such that no barcode
sequence was less than 4 changes away from its closest
sequence match). In theory, this allows single nucleotide
errors to be corrected, and two errors to be detected,
without reporting the wrong barcode. Here we report a
set of 384 barcodes with an edit distance of 5 between
any two members, allowing single base error correction,
three base error detection and requiring at least 4 sequen-




For the SASI-Seq approach to work, a fragment or set of
fragments was required that would be inexpensive, easily
identified and resistant to degradation and loss during
Illumina library preparation. One of the most common
variable steps in the library preparation process is size
selection [24], which can yield very tight (+/- 10 bp) or
very broad (+/- 400 bp, or greater) fragment size ranges.
In order to prevent the SASI fragments being lost during
size selection, we therefore envisioned a set of three
fragments of different sizes, approx. 200 bp, 400 bp and
600 bp that would be evenly spaced within the range of
fragment size distributions commonly used for Illumina
sequencing.
The viral genome PhiX 174 is easily one of the most
commonly sequenced genomes, as it is often used as an
internal control during Illumina sequencing [25,26]. As
such, it likely has a perfect reference and bioinformatics
pipelines have been written to remove PhiX reads from
Illumina datasets. We therefore designed our spike-in
fragments to represent discrete segments of the PhiX
genome around a common core. To do this, we used the
program Oligo 6 [27] to design a set of primers against
the NC_001422.1 Genbank reference sequence, that gave
three fragments of approximately 200 bp, 400 bp and
600 bp from a common reverse primer and that had
roughly equal Tm and priming efficiencies. The best
primer pairs had forward primers at positions 926, 743
and 571 and a reverse primer at position 1123 giving
amplicons of 214, 397 and 568 bp respectively. In order
to add a unique signature to these fragments that could be
uniquely associated with a particular sample, we placed a
unique sequence barcode from our set of Illumina barcode
sequences at the 5’ end of each forward primer [28]. These
barcodes were designed using a Hamming script [22,23]
that considers that the major error mode of Illumina
sequencing is substitution errors and ensures that no
two barcodes are less than 4 base substitutions apart. This
enables single error correction i.e. if a barcode sequence
gains an error during sequencing it will be one base away
from the perfect sequence and can be counted as thatoriginal barcode. A barcode sequence has to gain at least
three errors before it will be falsely counted as an alterna-
tive barcode. With the Illumina error rate less than 1%
[29] this should occur at a frequency of less than 1 in 106.
For the purposes of both this application and for multi-
plexing during Illumina sequencing we sought to con-
struct a set of 384 such barcodes that included our
previous set of 8mer 96 multiplexing barcodes [19,30,31].
To do this we found we needed to expand the barcode
word length to be a 9mer, so assigned the 9th base as A in
the first 167 barcodes in the set as this is the first base of
the Illumina adapter sequence following the run of bar-
code bases (for 9mer barcode sequences see Additional
file 1: Table S1).
Initial SASI fragment investigation experiments
In order for this approach to work it was necessary to
demonstrate that the SASI fragments remain within a
DNA sample once added and could not be degraded or
processed away. For these tests SASI amplicons were
generated with barcode tag #1 at both ends, as described
in Methods. We sought to determine whether or not the
fragments were sheared using typical physical shearing
conditions employed during Illumina library construction.
500 ng aliquots of human genomic DNA were spiked with
0.5 ng of SASI fragment mixture and sheared using a
Covaris focused acoustic shearing device to produce
average fragment sizes of 200 bp, 300 bp, 400 bp and
500 bp respectively. Illumina sequencing libraries were
constructed from each sheared DNA sample and with
each library receiving a different P7 indexing barcode
sequence. The libraries were mixed in equimolar propor-
tions and sequenced on an Illumina MiSeq instrument.
From each indexed library we analysed the fraction of
reads that shared similarity to the PhiX reference sequence
(Figure 2). This clearly demonstrated that the majority of
the SASI fragments were broken during shearing, that
virtually none of the larger 568 bp amplicon remained,
but approximately 10% of detected fragments were intact
214 and 397 bp amplicons.
In order to investigate the effect of different size selection
protocols on the levels of detectable SASI fragments, we
again took 500 ng aliquots of human genomic DNA spiked
with 0.5 ng of SASI fragment mixture, sheared to an aver-
age fragment size of 300 bp and made Illumina sequencing
libraries using a variety of size selection approaches, before
sequencing as a multiplexed pool. We have previously
found the Sage Science Pippin Prep gives the tightest dis-
tribution of fragment sizes during fractionation [24]. We
therefore used the Pippin Prep to separate as tight a size
fraction as possible centred around 300 or 500 bp, i.e.
approximately halfway between the sizes of the SASI
amplicons. We made libraries including this size frac-



























Figure 2 Percentage of SASI fragments detected after different Covaris shearing regimes. With all shearing conditions, some intact A, B
and C fragments with barcode number 1 (here referred to as A1-R1, B1-R1 or C1-R1) are detected. In general the more intense the shearing regime,
the greater number of partial, or broken amplicons (fragments with terminal sequences A1, B1, C1 or R1 at one end and an internal sequence at the
other end, here referred to as A1-broken, B1-broken, C1-broken or R1-broken), are detected. The longer amplicons are more susceptible to breakage
during shearing than the smallest A1-R1 amplicon (214 bp).
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fractionate tight 300 and 500 bp fragments; agarose-gel
electrophoresis to size fractionate a tight 300 bp size
fraction; AMPure beads to purify >200 bp fragments and
400-600 bp fragments; and Agilent SureSelect custom ex-
ome enrichment. The results demonstrated the persistent
nature of the SASI fragments in that we were able to de-



























Percentage SASI reads detected in samp
Figure 3 Percentage of SASI fragments detected after different size sele
“normal” 200-600 bp SPRI library were SASI-fragments which corresponds wel
SASI fragments could still be detected, albeit at a lower level.including after Pippin Prep fractionation (for mapped
insert-size distributions, see Additional file 2: Figure S1),
and perhaps surprisingly, even after SureSelect target
enrichment, albeit at a very low level.
Following the inclusion of a specific probe (10 μM
final concentration, for details see Methods) we found
that SASI fragments could be reproducibly detected fol-















le dataset after various size selection regimes
ction regimes. Approximately 0.1% of the sequences obtained from the
l to the 0.1% initial spike-in dosage. With more stringent size selection,
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shown).Optimisation of multiplexing barcode sequences
Ideally, sequence multiplexing would be pure in the sense
that a single sample would have a unique and exclusive
barcode sequence. Also for SASI-Seq to have maximum
sensitivity, a single sample would only display the intended
barcode sequence(s). However, there are two mechanisms
by which background contamination can occur: i) cross-
contamination can occur between barcoding oligonucleo-
tides during synthesis and subsequent processing and ii)
errors during sequencing can lead to sequence drift such
that an alternate barcode sequence is read.
In previous experiments in which samples were deliber-
ately omitted from multiplexed library pools, we noticed
that such samples could still be detected at a low level. In
order to determine the best processing and purification
approach for oligo synthesis, we made a set of libraries
using barcoded multiplexing PCR primers that had been
purified by HPLC (from Company A) or PAGE purifica-
tion (Company B), or using IDT TruGrade processing
(custom service, Integrated DNA Technologies, Iowa,
USA). We deliberately did not open the tubes containing
some of the barcode primers, but included those barcodes
in the sequence dataset analysis, looking to see what frac-
tion of reads were attributed to those barcodes, although
they had not been used (Additional file 3: Table S2). With
HPLC or PAGE purification, approximately 0.56% and
0.34% of reads mapped to the missing barcodes. With
TruGrade this was dramatically reduced to just 0.03%.
The set of barcode sequences used initially was designed
to be 4 bases apart and to tolerate one mismatch. In order
to investigate the origin of these mis-attributed barcodes,
we tabulated the number of perfect matches and the num-
ber of matches within one mismatch against each barcode
in the 384 set (Additional file 4: Table S3 sheet1). We
found that some matches to absent barcode sequences
had higher levels of perfect matches (than single-change
mismatches) to other barcodes synthesised within the
same batch, indicating cross-contamination in the lab
or during synthesis. Other mis-attributed barcodes had
higher numbers of hits allowing for one mismatch than
they did to perfect matches, indicating that those
matches were due to sequence drift from other barcodes
as a result of sequencing error. We looked at the level of
barcode mis-attribution in other runs, two of which are
illustrated in Additional file 4: Table S3 as sheets 2 and 3.
Whilst in some runs mis-attribution was primarily due to
perfect matches indicating lab contamination (Additional
file 4: Table S3 sheet2), upto 0.2% mis-attribution was
observed due to sequence drift (Additional file 4: Table S3
sheet 3).In order to make SASI-Seq as sensitive as possible,
and sample multiplexing as distinct as possible, we sought
to reduce this background level of barcode mis-attribution
by redesigning our 384 plex barcode set such that they
were at least 5 bases different from the closest other
barcode sequence. When using single error correction,
this would tolerate 3 sequencing errors, since at least 4
sequencing errors would be required to potentially con-
vert each to within one base of an alternative barcode.
This required increasing the barcode length to 11 bases,
the sequences of which are given in Additional file 5:
Table S4.
We ordered Illumina PCR multiplexing oligos with
these 384 different 11-mer barcode sequences from IDT
to TruGrade purity in four 96 well plates, and validated
that purity by checking for the presence of unexpected
barcodes. Briefly we amplified an Illumina adapter ligated
fragment library of the S. aureus TW20 strain, in the pres-
ence of each of the 384 barcoded primers, in four 96 well
plates. After PCR we made two multiplexed library pools,
one containing an equal volume of all odd number
barcoded libraries and the other with an equal volume
of all the even number barcoded libraries. We used an
8-channel pipette for this purpose, so that we could
pipette whole columns without error. Each pool was
purified, quantified and run on an Illumina MiSeq to
determine the frequency of each barcode (Additional
file 6: Table S5). The incidence of mis-attribution in
each experiment was less than 0.005%, of which 75% and
83% respectively were perfect matches, demonstrating the
highly discriminatory nature of these barcodes which
would be a prerequisite for sensitive cross-contamination
detection using SASI-Seq.
Sample assurance using SASI-Seq
To test the performance of SASI-Seq, we prepared a
set of 96 multiplexed libraries from samples that had
been spiked with 0.1% SASI fragments containing a
unique 11-mer barcode at one end. The reads from
each library were segregated according to the barcode
sequence and each library dataset mined for reads originat-
ing from the SASI spike-in fragments. The results are best
visualised as a tabulated matrix of sequencing barcode
versus spike-in barcode for each library (e.g. (Figure 4), full
results in Additional file 7: Table S6). The number of SASI
specific reads varies between samples, but for each their
representation roughly approximates the 0.1% spike-in
level. Variation is probably a result of a number of factors
including variation in the number of reads for each
Illumina barcode data set, accuracy of quantification of
both DNA sample and SASI fragments as well as pipet-
ting accuracy at low volumes. In separate experiments
(not shown) different relative levels of sequencing bar-
codes and SASI fragments were observed indicating
SASI spike-in barcode number
Library barcode %SASI reads in dataset 1 2 3 4 5 6 7 8
========== ======= ==== ==== ==== ==== ==== ==== ==== ====
#1 0.107 1632 0 0 0 0 0 0 0
#2 0.223 0 6200 0 0 0 0 0 0
#3 0.144 0 0 4234 0 0 0 2 0
#4 0.124 0 0 0 2365 0 0 0 0
#5 0.090 0 0 0 0 1137 0 0 0
#6 0.084 0 0 0 0 0 943 2 0
#7 0.116 0 0 0 0 0 0 2328 0
#8 0.092 0 0 0 0 0 0 0 1229
Figure 4 Demonstration of the utility of SASI-Seq for sample assurance.
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others as has been observed with some “in-line” barcoding
sets (e.g.[32]).
For the most part, the only SASI fragments detected
in each library dataset were those that were expected.
There were, however, a small number of hits to other
SASI barcode sequences in some of the libraries. On
analysis, these were found to be perfect matches indi-
cating cross-contamination during processing rather than
sequence error resulting in barcode cross-talk.Detecting sample swaps and cross-contamination
using SASI-Seq
To demonstrate that we could reliably use SASI-Seq to
detect sample swaps and cross-contamination events we
deliberately mixed samples with known spike-ins. Sam-
ple swaps could be identified quite readily, an example
of this is shown in (Figure 5), in which two consecutive
samples were purposely transposed.
We next tested the power by which we could detect
cross-contamination by deliberately mixing in samples
containing other spike-in barcodes at known levels. Spe-
cifically, samples in triplicate containing 0.1% uniquely
tagged spike-ins were deliberately cross-contaminated by
adding another sample, containing 0.1% spike-ins with
SASI barcode #77, to 10%, 1% and 0.1% relative to the
concentration of the original sample. At the 0.1% level ofSASI Sp
Library 
barcode











Figure 5 Demonstration of the utility of SASI-Seq for detecting sampoverall spike-in, cross-contamination down to 1% could
be reliably detected above the background contamination
and sample-to-sample SASI read variation, within the
experiment (Figure 6). The low level of background
contamination seen in this experiment was probably a
result of small splashover events during library preparation
since the contaminants had perfect matches and no such
contamination was observed when individual libraries were
remade manually (results not shown).
Universal SASI-Seq
In order to make the SASI fragment design applicable to
Nextera library preparation and PCR-based enrichment
approaches, we added the sequences TCGTCGGCAGC
GTCAGATGTGTATAAGAGACAG and GTCTCGTGG
GCTCGGAGATGTGTATAAGAGACAG, that are nor-
mally introduced via the Nextera reaction [33], to the
respective 5’ ends of forward and reverse primers used
in SASI fragment generation. This enabled the SASI
fragments to be amplified using the standard Nextera
PCR primers, or using primers with these sequences
that could easily be included in any PCR enrichment
panel (results not shown).
SNP calling
Since this approach involves adding foreign DNA to
samples under study we had a slight concern that SASIike in barcode number
5 36 37 38 39
== ==== ==== ==== ====
0 0 0 0 0
0 0 0 0 0
0 938 0 0 0
40 0 0 0 0
0 0 2704 2 0
0 0 0 395 0
0 0 0 0 1298
0 0 0 0 0
le swaps.
Library %SASI reads Percent SASI Spike in barcode number
Barcode in dataset contamination 48 49 50 51 52 53 54 55 56 57 77
==================== ============== ==== ==== ==== ==== ==== ==== ==== ==== ==== ====
#48 0.031 0.0% 683 0 0 0 0 0 0 0 0 2 0
#49 0.133 10.0% 0 3165 0 0 0 0 0 0 0 0 1044
#50 0.052 10.0% 2 1 456 2 0 0 0 0 0 0 588
#51 0.084 10.0% 0 0 0 1564 4 0 0 0 0 0 374
#52 0.042 1.0% 0 0 0 4 1253 0 0 0 2 2 71
#53 0.039 1.0% 0 0 0 0 0 1080 0 0 0 0 44
#54 0.059 1.0% 0 0 0 0 0 0 2567 0 0 0 56
#55 0.082 0.1% 0 0 0 0 0 0 0 2289 0 0 6
#56 0.066 0.1% 0 0 0 0 2 0 0 0 1182 0 2
#57 0.050 0.1% 0 0 0 0 0 0 0 0 0 1524 4
Figure 6 Demonstration of the utility of SASI-Seq for detecting cross-contamination.
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data and interfere with subsequent analysis, leading to
false SNP calling and elevated false positive rates. To
examine this possibility we sequenced the genome of
Staphylococcus aureus TW20, for which we had a complete
genome sequence [34], both with and without the inclusion
of SASI fragments. Variant analysis of the resulting datasets
showed that neither dataset had any variants compared to
the reference thus providing assurance that SASI fragments
do not lead to false SNP calls.
Discussion
Mistakes resulting in sample swaps and cross-contamin-
ation can, and undoubtedly do, happen in the laboratory,
but no one knows with certainty the true frequency of
such events. Due to the rapid uptake and power of NGS,
hundreds of thousands of genomes are now being se-
quenced per annum and that number is increasing. Such
throughput can only put strain on the upstream pipelines
that feed the sequencing instruments, potentially resulting
in more sample swaps and cross-contamination events
that could lead to false diagnosis, erroneous conclusions
or confuse statistical analyses searching for causative
mutations. Moreover, such events are often costly, as
investigations to determine the cause of the mistake and
determine the true identity of samples can be very time
consuming. Here we have demonstrated a simple, inex-
pensive and flexible method for sample assurance whereby
barcoded amplicons are spiked into samples as close as
possible to the source and stay with that sample through
the sequencing process. This technique has the ability
to provide peace of mind by reassuring the user that the
obtained sequence is from the desired sample.
Theoretically, there are no real restrictions on the
sequence of the amplicons used for this approach. We
chose here to use amplicons from a region of the PhiX
174 genome as we would be unlikely to sequence sucha genome in a real experiment. Therefore, there is little
chance of confusing SASI reads with those of the sample.
In order to retain flexibility we utilise a set of three frag-
ments that span the range of fragment sizes commonly
used in Illumina sequencing and demonstrate that those
fragments persist even after very tight size selection. If
one had a standardised protocol where all libraries
produced had the same insert size range, it may be pos-
sible to use just one such SASI fragment. Since virtually
all of the larger 568 bp fragment is fragmented during
shearing (Figure 2) it could be argued to be superfluous,
however we retain it to allow for the eventually whereby
larger size selected fragment libraries are prepared.
For probe-based target enrichment studies, we had
envisaged incorporation of a specific capture probe for
the region of the PhiX genome covered by the SASI
fragments. This approach appeared to work well in that
SASI fragment representation after selection was found
to be close to input levels. It was a surprise to us that the
SASI fragments could be reproducibly detected following
Agilent SureSelect exome target enrichment without
specific probes being present, and illustrates the “leaky”
nature of the solution hybrid capture technique. Whilst not
absolutely necessary we would recommend supplementa-
tion of the probe capture set with a SASI specific probe to
ensure reliability.
Similarly, the method is flexible enough to accom-
modate other enrichment approaches, provided the
SASI fragments are included in the experimental design.
In particular for PCR-based enrichment approaches, the
SASI fragment design would have to be modified
slightly to include sequences at the termini from which
the SASI fragments could be amplified, if primers an-
nealing to those regions were to be included in primer
panels. Extra flanking sequence is also required for sam-
ples bound for Nextera library preparation, in order that
the termini of the SASI fragments are appended with the
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Adding these sequences enables the fragments to be amp-
lified in the subsequent PCR step. Since this sequence
could be used for amplification in PCR-based enrich-
ment approaches, addition of this sequence at the ter-
mini of the SASI fragment oligos would be recommended
in order to provide sets of fragments with universal
application.
Almost by definition, Next-Generation Sequencing is
“massively parallel,” generating many millions of individual
sequence reads; therefore, there is considerable scope
for cross-contamination to be detected. There are several
means by which contamination can occur, including
not just physical contamination of one DNA sample
with another, but by cross-contamination of barcoding
oligonucleotides during manufacturers’ processing, or
in one’s own laboratory, and by misattribution following
sequencing error. Here we have addressed two of the
causes by which such contamination can occur. Notably
we have increased the edit distance on our Illumina
sample barcoding sequences to five, and identified optimal
barcoding oligonucleotide purification conditions.
Since we started barcoding libraries in 2009 we have sur-
veyed oligos at different purities from a number of manu-
facturers with similar results to those presented here.
Manufacturers’ literature suggest that HPLC should
give >85% purity of full length oligonucleotide and
PAGE >90% purity but no specifications or guarantees are
given in regard of cross-contamination by other oligonu-
cleotides. Ourselves, and collaborating NGS practitioners,
have noted that such cross-contamination is higher fol-
lowing HPLC purification so we have until now ordered
barcoding oligonucleotides with PAGE purification even
though it tends to give lower overall yields than if HPLC
purification is specified. Cross-contamination presumably
occurs due to use of common labware in the oligo-
nucleotide synthesis facility. IDT's TruGrade manufac-
turing utilizes manual and automated processing workflows
to minimize the chance of oligo-to-oligo interaction
throughout processing.
As a result of this investigation we list a set of 384 highly
discriminating barcodes that can have a background rate of
false attribution of less than 0.005%. Aside from its
application in sample assurance SASI-Seq could be
used for barcoding oligo QC. If one had a validated set
of samples containing previously determined SASI bar-
codes, one could amplify that set with each new batch
of barcoding oligos and any irregularities in indexing
barcode identity would be reported by the SASI bar-
codes detected. Once the barcoding oligo set and the
investigator’s library process have been certified “clean”,
SASI-Seq could also be used to measure sample-to-sample
or run-to-run contamination in next-generation sequencing
experiments.Here we have chosen to spike-in these uniquely tagged
SASI fragments at a level of approximately 0.1% of
the sample concentration. The presence of these frag-
ments does not sacrifice significant sequence yield and
sufficient numbers of identifiable SASI fragments allow
cross-contamination to be readily detected. At this spike-
in level sample identification and detection of sample
mix-ups and cross-contaminations can be reliably
detected down to 1% of the sample concentration. The
tested conditions represent a subset of those that could
be practically employed. The level of SASI fragment
spike-in could be varied according to the desired cross-
contamination detection sensitivity. With 96-plex sequen-
cing on a single HiSeq 2000 lane, e.g., the majority of
sample datasets had on the order of 1000 SASI reads. If
one wanted to multiplex 384 samples instead and retain
the same sensitivity, one would have to increase the
SASI spike-in level 4-fold to 0.4%. Conversely, if one
wanted to multiplex fewer samples, then the level of
spike-in could be reduced. Increasing the sensitivity to
detect cross-contamination ten-fold (to 0.1%), would
require increasing the spike-in level ten-fold. Thus the use
of SASI-Seq could be tailored to the requirements of the
individual laboratory and possibly the requirements of
individual experiments. Typical resequencing experiments
involving at least 30-fold coverage will be largely tolerant
of low levels of cross contamination but experiments
designed to identify rare variants in a population, or low
coverage sequencing experiments may be more sensitive.
The ability to estimate cross contamination levels would
then be valuable in reporting the level of background
noise, enabling confidence levels to be ascribed to obser-
vations and analysis settings (e.g. required minimal cover-
age) to be modified. Knowledge of cross contamination
levels could also be a valuable tool for operational moni-
toring and process optimization. Amongst the background
levels of contamination present in the results presented
here a 0.1% spike in level can cleanly report sample
contamination levels down to 1%. This is significant
since variation rarer than this is cannot be detected
above the level of sequencing error, unless specific rare
variant detection strategies are employed [35]. Since
such strategies can theoretically detect 1 error in one
billion they will be extremely sensitive to contamination
and as such best performed in isolation, in which case
SASI-seq would not be required.
Each laboratory may also want to consider the number
of unique SASI fragments it employs. Ideally each and
every sample would have a uniquely barcoded SASI
fragment set, but when sequencing very large numbers
of samples, that would be too expensive; each barcoded
oligonucleotide has to be individually synthesised and
SASI fragments need to be amplified, purified, quantified
and quality controlled. Additionally, barcode sequences
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would get very long. Equally, utilising a set of just 96 SASI
fragments is likely to be insufficient for a lab handling
thousands of samples each month. We have shown that
multiple SASI fragments can be added to a sample and
that the presence of each can be detected following sequen-
cing. Thus we envisage applying SASI-Seq in a combinatorial
fashion so as to introduce complexity. For example, if two
SASI fragments from a 96 uniquely barcoded set of SASI
fragments were added to each sample there would be a
maximal 4,560 degree of complexity ((96 × 95)/2), and if
one had a 384 uniquely barcoded set of SASI fragments
adding two SASI fragment sets per sample would give
73,536 possibilities. Though the application of SASI-Seq
on a lower level could be tracked manually, its large-scale
implementation requires LIMS tracking, registration of
SASI barcodes to sample and post-sequencing analysis
such that the appearance of the correct SASI barcode,
along with any unexpected barcodes, can be reported.
Conclusions
SASI-Seq is a simple, inexpensive and flexible tool that
enables sample assurance, allows deconvolution of sample
mix-ups and reports levels of cross-contamination between
samples throughout NGS workflows. Its application will
provide a guarantee that data generated originates from the
intended sample and only the intended sample. This should
increase the accuracy of epidemiological studies, increase
the power of causal variant detection and give increased




Human DNA was purchased from Promega (Cat. no.
G304A). Staphylococcus aureus TW20 genomic DNA was
a gift from Jodi Lindsay, St George's Hospital Medical
School, University of London.
SASI fragment preparation
The three SASI amplicons were prepared by PCR using
the following primers (obtained from IDT):
Forward A 214 bp fragment primers
{optional barcode sequence}GGCGCTCGTCTTTGGT
ATGTA
Forward B 397 bp fragment primers
{optional barcode sequence}TGAATTGTTCGCGTTT
ACCTT




{reverse complement of barcode sequence}GGCGTC
CATCTCGAAGEach amplification reaction comprised 1 ng of PhiX174
RFII DNA (NEB #N3022L), 200pM of appropriate forward
primer, 200pM reverse primer and 1× Kapa HiFi master-
mix (KK2602). All PCR was performed on an MJ Tetrad2
thermal cycler with the following conditions: 98°C for
2 minutes; 20 cycles of 98°C for 20 seconds, 55°C for
30 seconds, 72°C for 30 seconds; 72°C for 3 minutes.
Amplicons were purified using a 1:1 ratio of AMPure
XP beads (Beckman Coulter Inc.) and eluted in 30 μl of
10 mM Tris-HCl, pH8.5, prior to analysis on a Fragment
Analyzer (Advanced Analytical) and fluorimetric quantifi-
cation using Quant-iT™ PicoGreen ® dsDNA Reagent and
DNA standards of known concentration. Each set of three
SASI fragments bearing the same barcode was mixed in
equimolar amounts and adjusted to a final concentration
of 0.5 ng/μl. Barcoded SASI fragments were added to sam-
ples at a dosing of 0.1% which we considered would give
sufficient numbers of SASI reads to detect low level cross-
contamination without significantly sacrificing data yield.
Illumina library construction
DNA (0.5 μg in 100 μl of 10 mM Tris-HCl, pH8.5) was
sheared in an AFA microtube using a Covaris S2 device
(Covaris Inc.), with the following settings: for 200 bp
fragments (duty cycle 20, intensity 5, 200 cycles/burst,
90 sec), for 300 bp fragments (duty cycle 20, intensity 5,
200 cycles/burst, 45 sec), for 400 bp fragments (duty cycle
20, intensity 5, 200 cycles/burst, 30 sec) and for 500 bp
fragments (duty cycle 5, intensity 3, 200 cycles/burst,
80 sec).
Sheared DNA was purified by binding to an equal
volume of AMPure XP beads (Beckman Coulter, Inc.)
and eluted in 32 μl of 10 mM Tris-HCl, pH8.5. End-repair,
A-tailing and paired-end adapter ligation were performed
using NEBNext reagents from New England Biolabs,
with purification using a 1:1 ratio of AMPure XP beads
to sample between each reaction. After ligation, excess
adapters and adapter dimers were removed using two
Ampure XP clean-ups, first with a 1.1:1 ratio of standard
AMPure XP beads to sample, followed by a 0.7:1 ratio.
Adapter-ligated fragments were amplified using Kapa HiFi
polymerase (Kapa Biosystems cat. no. KK2602) as pre-
viously described [30] with 200 nM final concentration
of primer PE1.0 and modified multiplexing PE2.0
primers.
After PCR, excess primers and any primer dimer were
removed using two AMPure XP clean-ups, with a 0.7:1
ratio of AMPure XP beads. All libraries were quantified
by real-time PCR, using the SYBR Fast Illumina Library
Quantification Kit (Kapa Biosystems cat. no. KK4834),
prior to pooling and sequencing.
Libraries in 96-well microtitre plates were prepared as
above, with the following modifications. DNA was sheared
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TUBE plates (Covaris Inc., part no. 520078) using a
Covaris E210 instrument with the settings: duty cycle
10, intensity 5, 200 cycles/burst, 60 sec. PrePCR process-
ing was performed using a Beckman FxP dual arm liquid
handling platform. A Caliper Zephyr liquid handler was
used for a single post-PCR cleanup, using a 0.7:1 ratio of
AMPure XP beads to DNA.
Agarose-gel size selection
DNA (30 μl) was mixed with 6 μl of 6× loading dye
(Qiagen) and loaded into a well of a 2% low-range
Ultra-agarose gel (BioRad 161-3107) set within an
EM100 10 × 10 cm horizontal electrophoresis chamber
(Engineering and design plastics Ltd.) using TAE running
buffer [3]. The sample was run alongside a 10 μl aliquot
of low molecular weight DNA ladder (NEB, N3233L) at
6 V/cm for 2 hours, after which time the gel was stained
for 30 minutes in 50 ml of TAE buffer containing SYBR
green (Invitrogen) at 1/10,000 dilution. The gel was visual-
ized on a Dark Reader (Clare Chemical Research Inc.) and
gel slices containing DNA fragments of the desired size
ranges were excised with a scalpel. DNA was extracted
from gel slices using the Qiaquick Gel Extraction Kit
(Qiagen), with dissolution of the gel slice in QG buffer
at room temperature for 10 minutes* and eluted in 30 μl
of 10 mM Tris-HCl, pH8.5.
* We have noted previously [26] that use of the standard
Qiagen gel-extraction protocol with dissolution of the gel
slice at 55°C can result in the loss of very AT-rich sequences.
AMPure XP size selection
AMPure XP SPRI beads (Beckman Coulter Inc.) were
used according to the manufacturer’s protocol, with
binding for 5 minutes, two washes with 80% ethanol, air
drying for 10 minutes and elution into 30 μl of 10 mM
Tris-HCl, pH8.5. Unless stated otherwise, a 1:1 ratio
of beads to sample was used, resulting in removal of
most <200 bp fragments.
To select 400-600 bp fragments, DNA was double size
selected using AMPure beads by first adding a 0.6:1
(beads:sample) aliquot of beads to bind >600 bp mater-
ial. The supernatant was removed from these beads and
transferred to a fresh tube. To this supernatant an extra
0.12:1 aliquot of beads was then added to bind frag-
ments >400 bp. These beads were washed, dried and
DNA (containing fragments of mostly 400 to 600 bp)
eluted from them into 30 μl of 10 mM Tris-HCl, pH8.5.
Pippin prep size selection
DNA (30 μl) was mixed with 10 μl loading solution and
loaded into the well of a 2%-agarose cassette (Sage Science;
CSD2010 with ethidium bromide, or CEF2010 dye free)
and run according to the manufacturer’s instructions.DNA was collected from the elution port and purified
using the Qiaquick PCR Purification Kit (Qiagen), prior
to further use, to remove ethidium bromide. We found
that the Pippin Prep elution buffer is alkaline and so
eluted DNA does not bind well to Qiagen columns. To
overcome this issue, we routinely add 1 μl of 3 M sodium
acetate, pH5.2 to the eluate before adding the Qiagen
binding buffer.
Caliper labchip XT size selection
DNA (10 μl) was mixed with 2 μl of loading solution
and loaded into the sample well of a DNA 750 chip (part
no. 760541) and run according to the manufacturer’s
instructions.
SureSelect target enrichment
Whole exome targeted enrichment libraries were prepared
using the Agilent SureSelect XT Targeted Enrichment
system according to manufacturer’s protocols, except that
the adapters and PCR indexing primers outlined in the
Illumina Library Construction section above were used,
along with blocking oligos complementary to the indexing
primers containing universal deoxyinosine bases over the
index sequence.
Where we sought to actively enrich SASI fragments, we
included a single-stranded DNA probe complementary to
the region of the phiX genome present in all SASI frag-
ments into the SureSelect Human All Exon 50 Mb (ELID




GCGGCATACGCTCGGCG was synthesised as a 4nmole
scale ultramer from IDT and was included in the hybrid-
isation in a range of final concentration of 10 μM.
Illumina sequencing
Most samples were sequenced on an Illumina MiSeq
instrument with the appropriate length index read and
v2 chemistry. Runs were either 75, 100 or 130 base paired
end, though 50 base single-end sequencing was used
for barcode frequency determination. For the 96-sample
experiments, 75 base paired-end sequencing was performed
on an Illumina HiSeq.
To eliminate the possibility of any potential sample
carryover between MiSeq runs that may affect observed
background levels of barcode sequences, we scheduled
runs such that samples with different barcoding strategies,
or no barcoding, were alternated with runs employing the
barcoding schema here described.
Data processing
After sequencing, reads were mapped to each genome
reference sequence using SMALT [36]. SAMtools [37] was
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from the mapping output. SMALT was also used for
variant analysis.
Availability of supporting data
All datasets have been deposited in the ENA read archive
under accession number ERP001281. A list of the experi-
mental conditions pertaining to each sample submission is
given in s sample accession numbers please see Additional
file 8: Table S7.
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